EUVIMED · CrossrefJournal
Pulmonary Pharmacology & Therapeutics
ISSN 1094-5539 · Elsevier BV
Latest articles
First-in-human safety and pharmacokinetic evaluation of seralutinib, an investigational inhaled tyrosine-protein kinase inhibitor for pulmonary hypertension
Tectochrysin alleviates idiopathic pulmonary fibrosis via inhibiting PI3K/AKT/mTOR signaling pathway by targeting PI3K p85
Evaluation of the effect of modulator therapies on medication complexity in adult cystic fibrosis patients
Evodiamine protects against lung ischemia–reperfusion injury by attenuating SYK-associated TLR4/NLRP3 inflammasome activation and ferroptosis-related injury signatures
Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment
Editorial Board
The importance of biomarkers in the treatable-trait approach to chronic airway diseases
Editorial Board
Experimental modeling of pulmonary fibrosis and combined emphysema in mice using repeated doses of bleomycin and cigarette smoke extract
A retrospective review of concurrent versus sequential administration of intrapleural tissue plasminogen activator and dornase alfa for empyemas
Real-life impact of genotype and severity of lung disease on efficacy of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis
Bispecific domain antibody attenuates airway hyperresponsiveness and pulmonary inflammation in ovalbumin-lipopolysaccharide induced asthma model by inhibiting IL-23 and TNF-α
The efficacy and safety of inhaled antibiotics for pneumonia: A systematic review and meta-analysis
Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea
Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant
Ferroptosis mediates airway epithelial E-cadherin dysfunction in LPS-induced acute lung injury
Knockdown of HDAC10 inhibits POLE2-mediated DNA damage repair in NSCLC cells by increasing SP1 acetylation levels
m6A-modified miR-143-3p inhibits epithelial mesenchymal transition in bronchial epithelial cells and extracellular matrix production in lung fibroblasts by targeting Smad3
The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting
Tyvaso DPI: Drug-device characteristics and patient clinical considerations
Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
Impact of statin treatment and exposure on the risk of chronic allograft dysfunction in Chinese lung transplant recipients
Weight loss in nintedanib-treated patients with idiopathic pulmonary fibrosis
Development of an inhaled anti-TSLP therapy for asthma
Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities
Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate
Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammation
The immunomodulatory effects of macrolide antibiotics in respiratory disease
HDAC8-inhibitor PCI-34051-induced exosomes inhibit human bronchial smooth muscle cell proliferation via miR-381-3p mediated TGFB3
Inhaled bronchodilators use and clinical course of adult inpatients with Covid-19 pneumonia in Spain: A retrospective cohort study
EUVIMED